| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.27 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.1 | 0.08 |